Invention Grant
- Patent Title: Combination therapies for treatment of cancer
-
Application No.: US15924039Application Date: 2018-03-16
-
Publication No.: US10933134B2Publication Date: 2021-03-02
- Inventor: Jonathan Coleman , Philip A. Watson , Kwanghee Kim , Avigdor Scherz
- Applicant: Memorial Sloan Kettering Cancer Center , Yeda Research and Development Co. Ltd., at the Weizmann Institute of Science
- Applicant Address: US NY New York; IL Rehovot
- Assignee: Memorial Sloan Kettering Cancer Center,Yeda Research and Development Co. Ltd., at the Weizmann Institute of Science
- Current Assignee: Memorial Sloan Kettering Cancer Center,Yeda Research and Development Co. Ltd., at the Weizmann Institute of Science
- Current Assignee Address: US NY New York; IL Rehovot
- Agency: Dechert LLP
- Main IPC: A61K41/00
- IPC: A61K41/00 ; A61P35/00 ; A61K31/4166 ; A61K38/08 ; A61K47/64 ; A61N5/06
Abstract:
A method for treatment of prostate cancer or benign prostate hyperplasia by combination therapy comprising administering to a patient an androgen-deprivation therapy agent and a bacteriochlorophyll derivative followed by photodynamic therapy (PDT) or vascular-targeted photodynamic therapy (VTP).
Public/Granted literature
- US20180296675A1 COMBINATION THERAPIES FOR TREATMENT OF CANCER Public/Granted day:2018-10-18
Information query
